{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:42:44Z","timestamp":1761709364669,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000109","name":"Prostate Cancer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000145","name":"Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","award":["201201232"],"award-info":[{"award-number":["201201232"]}],"id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","award":["D2013-36"],"award-info":[{"award-number":["D2013-36"]}],"id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["289792"],"award-info":[{"award-number":["289792"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.brachy.2017.04.242","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T14:15:39Z","timestamp":1496326539000},"page":"797-805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical factors and dosimetry associated with the development of prostate brachytherapy\u2013related urethral strictures: A matched case\u2013control study"],"prefix":"10.1016","volume":"16","author":[{"given":"Sandeep","family":"Singhal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad F.","family":"Jamaluddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald S.","family":"Sloboda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Parliament","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawaid","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2017.04.242_bib1","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.ijrobp.2009.03.049","article-title":"Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy","volume":"76","author":"Hinnen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.04.242_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.radonc.2010.03.004","article-title":"Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with iodine-125 monotherapy over 10 years","volume":"96","author":"Munro","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.04.242_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2010.05.042","article-title":"Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience","volume":"81","author":"Sylvester","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.04.242_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1464-410X.2002.02983.x","article-title":"125Iodine prostate brachytherapy: Outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics","volume":"90","author":"Henderson","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2017.04.242_bib5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2017.04.242_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.urology.2013.09.009","article-title":"SIU\/ICUD consultation on urethral strictures: Epidemiology, etiology, anatomy, and nomenclature of urethral stenoses, strictures, and pelvic fracture urethral disruption injuries","volume":"83","author":"Latini","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2017.04.242_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1464-410X.2011.10864.x","article-title":"Posterior urethral complications of the treatment of prostate cancer","volume":"110","author":"Mundy","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2017.04.242_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1200\/JCO.1999.17.2.517","article-title":"Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage","volume":"17","author":"Zelefsky","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.04.242_bib9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(05)00681-6","article-title":"Risk factors for the development of prostate brachytherapy related urethral strictures","volume":"175","author":"Merrick","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2017.04.242_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0360-3016(99)00525-8","article-title":"Temporal resolution of urinary morbidity following prostate brachytherapy","volume":"47","author":"Merrick","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.04.242_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1538-4721(02)00055-7","article-title":"The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy","volume":"1","author":"Crook","year":"2002","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.04.242_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0360-3016(02)04600-X","article-title":"Long-term urinary quality of life after permanent prostate brachytherapy","volume":"56","author":"Merrick","year":"2003","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2017.04.242_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0360-3016(01)01811-9","article-title":"The dosimetry of prostate brachytherapy-induced urethral strictures","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.04.242_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2012.06.001","article-title":"Correlation between prostate brachytherapy-related urethral stricture and peri-apical urethral dosimetry: A matched case-control study","volume":"104","author":"Earley","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.04.242_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brachy.2003.07.001","article-title":"Technical improvement in permanent seed implantation: A two-stage brachytherapy system. Description and comparison with current technique","volume":"3","author":"Grimm","year":"2004","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.04.242_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2007.01.014","article-title":"Tumour and target volumes in permanent prostate brachytherapy: A supplement to the ESTRO\/EAU\/EORTC recommendations on prostate brachytherapy","volume":"83","author":"Salembier","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2017.04.242_bib17","first-page":"3136","article-title":"Applied regression analysis","volume":"19","author":"Skovgaard","year":"1998"},{"key":"10.1016\/j.brachy.2017.04.242_bib18","first-page":"661","article-title":"Some comments on C P","volume":"15","author":"Mallows","year":"1973","journal-title":"Technometrics"},{"key":"10.1016\/j.brachy.2017.04.242_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1214\/aos\/1176344136","article-title":"Estimating the dimension of a model","volume":"6","author":"Schwarz","year":"1978","journal-title":"Ann Stat"},{"key":"10.1016\/j.brachy.2017.04.242_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Automat Contr"},{"key":"10.1016\/j.brachy.2017.04.242_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.wep.2014.03.001","article-title":"Model selection and Akaike Information Criteria: An example from wine ratings and prices","volume":"3","author":"Snipes","year":"2014","journal-title":"Wine Econ Policy"},{"key":"10.1016\/j.brachy.2017.04.242_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0360-3016(93)90188-2","article-title":"A CT-based evaluation method for permanent implants: Application to prostate","volume":"26","author":"Roy","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.04.242_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0360-3016(94)00599-G","article-title":"Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy","volume":"32","author":"Wallner","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.04.242_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.juro.2007.03.126","article-title":"Incidence of urethral stricture after primary treatment for prostate cancer: Data from CaPSURE","volume":"178","author":"Elliott","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2017.04.242_bib25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijrobp.2010.10.009","article-title":"Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer","volume":"82","author":"Mohammed","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.04.242_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1748-717X-9-122","article-title":"Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer","volume":"9","author":"Ghadjar","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2017.04.242_bib27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2004.12.068","article-title":"Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity","volume":"62","author":"Allen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.04.242_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00345-015-1608-2","article-title":"Observations and outcomes of urethroplasty for bulbomembranous stenosis after radiation therapy for prostate cancer","volume":"34","author":"Rourke","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.brachy.2017.04.242_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijrobp.2010.03.019","article-title":"Can images obtained with high field strength magnetic resonance imaging reduce contouring variability of the prostate?","volume":"80","author":"Usmani","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.04.242_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.brachy.2014.02.002","article-title":"Single-nucleotide polymorphisms studied for associations with urinary toxicity from 125I\u00a0prostate brachytherapy implants","volume":"13","author":"Usmani","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.04.242_bib31","first-page":"S53","article-title":"An exploratory model to\u00a0predict\u00a0the likelihood of radiation toxicity of a prostate cancer\u00a0patient after treatment incorporating genomic, clinical\u00a0and dosimetric variables","volume":"116","author":"Parliament","year":"2015","journal-title":"Radiother Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117303458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117303458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:13:03Z","timestamp":1761531183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472117303458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1538472117303458"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2017.04.242","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical factors and dosimetry associated with the development of prostate brachytherapy\u2013related urethral strictures: A matched case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2017.04.242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Inc. on behalf of American Brachytherapy Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}